Profil:
Sopharma ADSOPHARMA AD (63/2017) INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDING 30 JUNE 2017
Report no 63/2017
Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.
1. Financial Statements
2. Notes to the Financial Statements
3. Management report
4. Templates of the financial reports approved by the Bulgarian FSC
5. Declaration of the responsible directors
6. Insiders' information
7. Additional information
8. List of insider information under Art. 7 of Regulation (EU) 596/2014
Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1
kom espi zdz